Steward Partners Investment Advisory’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Steward Partners Investment Advisory’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$685K	Buy	+23,593	New	+$685K	﹤0.01%	1358
2025 Q1	–	Sell	-500	Closed	-$11.3K	–	4080
2024 Q4	$11.3K	Sell	500 -151	-23%	-$3.63K	﹤0.01%	3047
2024 Q3	$16K	Hold	651	–	–	﹤0.01%	2748
2024 Q2	$15.1K	Hold	651	–	–	﹤0.01%	2635
2024 Q1	$15.7K	Hold	651	–	–	﹤0.01%	2630
2023 Q4	$15K	Hold	651	–	–	﹤0.01%	2532
2023 Q3	$13.2K	Hold	651	–	–	﹤0.01%	2478
2023 Q2	$15.2K	Hold	651	–	–	﹤0.01%	2416
2023 Q1	$15.1K	Hold	651	–	–	﹤0.01%	2370
2022 Q4	$16.4K	Hold	651	–	–	﹤0.01%	2338
2022 Q3	$17K	Hold	651	–	–	﹤0.01%	2289
2022 Q2	$19K	Hold	651	–	–	﹤0.01%	2242
2022 Q1	$22K	Hold	651	–	–	﹤0.01%	2311
2021 Q4	$29K	Hold	651	–	–	﹤0.01%	2160
2021 Q3	$33K	Buy	+651	New	+$33.9K	﹤0.01%	2082

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Steward Partners Investment Advisory's IDNA Position: Q1 2026 in Review

Steward Partners Investment Advisory opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2026: 23,593 shares worth $685K. The stake represents ﹤0.01% of the portfolio and ranks #1358 among its holdings. This is a return to the name: Steward Partners Investment Advisory previously reported a position in IDNA as recently as Q4 2024.

Steward Partners Investment Advisory first reported a position in IDNA in Q3 2021 and has held it in 15 quarters since. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

Steward Partners Investment Advisory held 23,593 shares of iShares Genomics Immunology and Healthcare ETF worth $685K as of Q1 2026.
iShares Genomics Immunology and Healthcare ETF was a new Steward Partners Investment Advisory position in Q1 2026.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #1358 holding.
Steward Partners Investment Advisory first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2021 and has held it in 15 quarters since.
60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.